These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2160186)

  • 1. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of placental proteases in bradykinin (BK) degradation.
    Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
    Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N.
    Drapeau G; Chow A; Ward PE
    Peptides; 1991; 12(3):631-8. PubMed ID: 1656406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M; Jin HY; Katori M; Sunahara N
    Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinin receptor classification.
    Regoli D; Jukic D; Tousignant C; Rhaleb NE
    Agents Actions Suppl; 1992; 38 ( Pt 1)():475-86. PubMed ID: 1334627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
    Cyr M; Lepage Y; Blais C; Gervais N; Cugno M; Rouleau JL; Adam A
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H275-83. PubMed ID: 11406494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II.
    Togo J; Burch RM; DeHaas CJ; Connor JR; Steranka LR
    Peptides; 1989; 10(1):109-12. PubMed ID: 2546127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some characteristics of a peptidyl dipeptidase (kininase II) from rat CSF: differential effects of NaCl on the sequential degradation steps of bradykinin.
    Yoshida T; Nosaka S
    J Neurochem; 1990 Dec; 55(6):1861-9. PubMed ID: 2172462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of kinins on angiotensin I conversion in the local circulation.
    Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Clin Exp Hypertens A; 1990; 12(4):551-69. PubMed ID: 2196127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents.
    Sheikh IA; Kaplan AP
    Arthritis Rheum; 1987 Feb; 30(2):138-45. PubMed ID: 3030335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer.
    Maeda H; Matsumura Y; Kato H
    J Biol Chem; 1988 Nov; 263(31):16051-4. PubMed ID: 3182782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of kininase from rat isolated hearts during myocardial ischaemia.
    Ahmad M; Zeitlin IJ; Parratt JR
    Immunopharmacology; 1996 Jun; 33(1-3):299-300. PubMed ID: 8856168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Biochem Biophys Res Commun; 1988 Jan; 150(1):511-6. PubMed ID: 3337729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.